Learn about the use of checkpoint inhibitors in patients with NSCLC.
This activity is intended for nurses and advanced practice nurses.
The goal of this activity is to increase competence surrounding the use of immune checkpoint inhibitors for the treatment of patients with non-small cell lung cancer (NSCLC).
Approximate Time to Complete: 35 minutes
Course Available Beginning: Jan. 18, 2017
Developed through a partnership between SITC and Medscape.
Upon completion of this activity, participants will be able to:
- Have increased knowledge regarding the clinical data of immune checkpoint inhibitors in the treatment of non-small cell lung cancer (NSCLC)
- Have greater competence related to effective communication strategies in the management of patients with NSCLC who receive immune checkpoint inhibitors
- Have greater competence related to incorporating best practices for managing immune checkpoint inhibitor-related adverse events